AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
USANA Health Sciences Inc
XNYS · usd
SIC 2833 · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
FIGI BBG001S79BP0
13.96▼ 0.56 (-3.86%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
14.52
Day's Range
13.96 – 14.51
52-Week Range
12.57 – 23.59
Volume
169.2K
Avg Volume
173.2K
Share Statistics
Shares Outstanding
Employees
1,570
Exchange
XNYS
Listed
1993-04-22
Share count as of August 11, 2026

USANA Health Sciences Inc (USNA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about USANA Health Sciences Inc (USNA)
What is USANA Health Sciences Inc's Market Cap?
USANA Health Sciences Inc's Market Cap is $257.9M, based on as-reported figures from SEC (XBRL) filings.
What is USANA Health Sciences Inc's Enterprise Value?
USANA Health Sciences Inc's Enterprise Value is $89.4M, based on as-reported figures from SEC (XBRL) filings.
What is USANA Health Sciences Inc's Price / Sales?
USANA Health Sciences Inc's Price / Sales is 0.3×, based on as-reported figures from SEC (XBRL) filings.
What is USANA Health Sciences Inc's EV / Revenue?
USANA Health Sciences Inc's EV / Revenue is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is USANA Health Sciences Inc's EV / EBITDA?
USANA Health Sciences Inc's EV / EBITDA is 2.9×, based on as-reported figures from SEC (XBRL) filings.
What is USANA Health Sciences Inc's Revenue (TTM)?
USANA Health Sciences Inc's Revenue (TTM) is $913.4M, based on as-reported figures from SEC (XBRL) filings.
What is USANA Health Sciences Inc's Net Income (TTM)?
USANA Health Sciences Inc's Net Income (TTM) is -$22.2M, based on as-reported figures from SEC (XBRL) filings.
What is USANA Health Sciences Inc's EBITDA?
USANA Health Sciences Inc's EBITDA is $31.4M, based on as-reported figures from SEC (XBRL) filings.
What is USANA Health Sciences Inc's Diluted EPS (TTM)?
USANA Health Sciences Inc's Diluted EPS (TTM) is -1.20, based on as-reported figures from SEC (XBRL) filings.
What is USANA Health Sciences Inc's EBITDA Margin?
USANA Health Sciences Inc's EBITDA Margin is 3.4%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · USNAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJul 4, 2026Apr 4, 2026Jan 3, 2026Sep 27, 2025Jun 28, 2025Mar 29, 2025Dec 28, 2024Sep 28, 2024Jun 29, 2024Mar 30, 2024Dec 30, 2023Sep 30, 2023Jul 1, 2023Apr 1, 2023Dec 31, 2022Oct 1, 2022
Net sales
YoY growth-5.3%+0.3%+5.9%+6.7%
Cost of sales
Gross profit
% of revenue78.3%76.2%78.2%77.2%
Operating expenses:
Brand Partner incentives
Selling, general and administrative
Goodwill impairment———
Total operating expenses
% of revenue87.3%70.7%76.5%76.6%
(Loss) earnings from operations
% of revenue-9.0%5.5%1.7%0.6%
Other income (expense):
Interest income
Interest expense
Other, net
Other income (expense), net
(Loss) earnings before income taxes
Income taxes
Net (loss) earnings
% of revenue-12.5%2.8%-0.7%-3.1%
Net (loss) earnings attributable to redeemable noncontrolling interest
Net (loss) earnings attributable to USANA
% of revenue-9.6%3.0%-0.8%-3.1%
(Loss) earnings per common share attributable to USANA
Basic (in dollars per share)
Diluted (in dollars per share)
Comprehensive income (loss):
Net (loss) earnings——
% of revenue-12.5%——-3.1%
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment
Tax (expense) benefit related to foreign currency translation adjustment
Other comprehensive income (loss), net of tax
Comprehensive income (loss)
Comprehensive (loss) income attributable to redeemable noncontrolling interest
Comprehensive (loss) income attributable to USANA